This page is intended for members of the public in the UK seeking information on Neuraxpharm UK business
NXUK/2025/01 | March 2026
This page is intended for members of the public in the UK seeking information on Neuraxpharm UK business
NXUK/2025/01 | March 2026
Neuraxpharm is a European leader in pharmaceuticals for disorders affecting the central nervous system (CNS). We have been specialists in this field since 1985 and our 40 years of experience we bring a wealth of knowledge into our research and commercialisation of CNS products.
We are experts in improving existing pharmaceutical forms and upgrading new products with the aim of delivering relevant improvements in the life and wellbeing of patients with neurological and psychiatric disorders.
We understand that central nervous system disorders greatly affect how a person feels, behaves, thinks and relates to others. Nothing motivates us more than seeking to help enhance their quality of life, and we work tirelessly, hand in hand with healthcare professionals and scientific communities across Europe.
Our porfolio includes more than 130 molecules and 50 brands, addressing a full spectrum of psychiatric and neurological disorders: Psychosis and Schizophrenia, Epilepsy, Multiple Sclerosis, Depression, Anxiety, Chronic and Neuropathic Pain.
With a focus on CNS, we develop and commercialise originator brands, biologic drugs, value-added medicines, generics and consumer healthcare products.
We continuously strive to offer a wide range of effective, high quality and affordable CNS treatment options in Europe. In parallel, our mission is to provide innovative solutions to cover the unmet needs of our patients.
Due to 40 years of specialisation, focus, knowledge and expertise in the central nervous system field, we have a strong market position in CNS in Europe
We have a direct presence in 23 European markets and an emerging presence outside Europe through affiliates and a global distribution network
We offer strong innovative solutions and a pipeline of Value-Added medicines and innovative assets to meet our CNS patients’ needs
By having proven commercial, market access and scientific expertise and capabilities, we are a partner of choice for CNS products in Europe. At Neuraxpharm, we remain close and responsive to the expectations and needs of our key partners
An agile, high performing, and results driven team, our focus is on making a positive impact on the lives of the CNS community
A vertically integrated company from molecule to market but with an attractive asset-light business model. Our flexible structure adapts to the capabilities required for the situation
*FY 2024
Our journey began in 2016 with the acquisition of Spanish and German companies specialised in CNS since 1985.
An Italian company was acquired in 2017, bringing a unique expertise in nutraceuticals and consumer health products to the group, opening the way to a more direct relationship with the end consumer.
France and the United Kingdom were then incorporated in 2018, as an acquired company and new affiliate respectively.
In 2019, expert companies were acquired in Czechia, Slovakia, Hungary and Switzerland and the Polish and Portuguese affiliates were founded.
Austria, Poland and the Republic of Ireland were incorporated in 2020 as acquired companies.
The steep growth that drove Neuraxpharm’s direct presence in Europe from two to 13 countries in just four years will continue, given the team’s aim of bringing our pharmaceuticals to all those in need of high-quality yet affordable medicines.
2020 also witnessed the acquisition of the market-leading prescription brand Buccolam® including global rights from Takeda, the only buccal midazolam approved across Europe. Buccolam® is currently commercialised in 18 countries in Europe.
Buccolam® was launched in Japan, the world’s second largest CNS market (Source: IQVIA).
In addition, a new business unit, based in Stockholm, was established to cover the country markets of Sweden, Norway, Finland, Denmark and Iceland. Through this expansion, Neuraxpharm strengthens its position as the leading CNS specialist in Europe with a direct presence in 18 countries.
Our plan to become the European Nº1 CNS Specialist continues with our expansion into Greece through the acquisition of a CNS specialized company covering Greece and Cyprus, plus the Netherlands is incorporated with a new affiliate.
The year 2022 sees the acquisition of more than 30 established global CNS brands of Sanofi, followed by our first digital health commercialization agreement to market a wearable device to predict epileptic seizures, and ends with the licensing agreement for the European rights of Leriglitazone, an orphan drug for a rare neurological disease.
A new subsidiary is established in Belgium covering Belgium and Luxembourg, completing our presence in the Benelux and strengthening our footprint in Europe by reaching 98% of the European CNS market due to our direct presence in 23 countries.
2023 sees an emerging presence outside Europe through our first two affiliates in LATAM: Brazil and Mexico.
API manufacturing plant, Inke, is divested in line with our focus on CNS.
2023 concludes with an agreement with TG Therapeutics to commercialise BRIUMVI®, a treatment for relapsing multiple sclerosis (RMS), outside the US.
Neuraxpharm expands operations into the Middle East to cover the six members of the Gulf Cooperation Council.
We further our commitment to protecting the environment by installing >400 photovoltaic panels at our facilities in Barcelona.
In product news, Neuraxpharm launches BRIUMVI® in Germany and receives a positive recommendation for the product from NICE UK, while Buccolam®, our epilepsy treatment for children, is granted a positive opinion by the CHMP to extend the indication to include adults. The end of 2024 is marked by our strategic alliance with Pharmathen to co-develop long-acting injectable psychiatric therapies.
The year 2025 begins with the acquisition of established treatments for narcolepsy, Provigil® and Nuvigil, cementing our presence in new and existing markets.
We have a direct presence in more than 23 countries in Europe, two in Latin America (Brazil and Mexico), one hub in the Middle East and access to more than 50 international countries with a global distribution and partnering network.
Our team has deep local expertise in CNS products in each of the countries in which we have our own subsidiary. In parallel, we work tirelessly to strengthen our presence worldwide through distribution or B2B agreements with other countries in EU or outside EU. At the same time, we seek to maintain and consolidate our relationships with healthcare professionals.
Barcelona (Sant Joan Despí), Spain
Headquarters
Production (Neuraxpharm Pharmaceuticals)
R&D Hub
Düsseldorf (Langenfeld), Germany
Headquarters
Our Executive Committee consists of experts with broad experience across pharmaceutical and related industries, with the aim to guide the organisation into a successful future.
We work with partners from around the globe, sharing the benefits of our long heritage in mental health and the central nervous system together with a wide offering in CNS. We are particularly focused on developping value-added products and innovative solutions to meet the needs of our patients.
We work with an innate passion and perseverence to move health forward for our customers and patients across the globe.
Neuraxpharm is a vertically integrated company
We own and operate a manufacturing facility in Spain, Neuraxpharm Pharmaceuticals, specialising in solid forms and with a vertically integrated value chain from Molecule to Market.
This integration provides us with the flexibility to launch innovative and value-added products swiftly, responding to market demand, while ensuring the highest standards of quality and scientific robustness.
Neuraxpharm is vertically integrated from Molecule to Market
Internal know-how across the whole value chain enabling strong flexibility and insight
Neuraxpharm owns and operates Neuraxpharm Pharmaceuticals, a global manufacturing company based in Spain.
NXUK/2025/03 | March 2026
Our corporate values are at the heart of everything we do. They guide us to fulfil our ambition as a responsible business committed to our talented and diverse employees, patients, society and the environment
Dynamic spirit – as we are a fast-moving company, active and energetic, always looking for growth and continuous improvement. We are swift in our decision-making and implementation processes to deliver relevant improvements in the lives and wellbeing of patients, while considering the impact on society and the environment.
Passionate heart – because we love what we do, and why we do it. The future of our patients, families and society depends on what we do in the present. They will always come first.
Expert & Excellent – as we build our leadership position in the CNS market, we offer a broad range of high-quality, cost-effective therapeutic options to improve the lives of patients and their families.
We encourage teamwork among our colleagues to set and achieve smart goals. We seek to develop each individual’s strengths in the face of every challenge. We never give up on our objectives.
Our porfolio includes more than 130 molecules and 50 brands, addressing a full spectrum of psychiatric and neurological disorders: Psychosis and Schizophrenia, Epilepsy, Depression, Anxiety, Chronic and Neuropathic Pain.
With a focus on CNS, we develop and commercialize originator brands, biologic drugs, value-added medicines, generics, medical cannabis and consumer healthcare products.
We continuously strive to offer a wide range of effective, high quality and affordable CNS treatment options in Europe. In parallel, our mission is to provide innovative solutions to cover the unmet needs of our patients.
This section of the website is intended for patients, parents and carers of patients, who have been prescribed a Neuraxpharm product by their healthcare professional.
If not a patient/parent/carer please select ‘cancel’ to return to Neuraxpharm UK homepage
You will be redirected back to the Neuraxpharm public homepage
NXUK 0225 18 Date of preparation February 2025
Please not the such website and its content have been construed in accordance with local laws and regulations, which may differ from the ones applicable to neuraxpharm.com/uk.
Please make sure to review the Privacy Policy and Legal Terms of any website located in a different geography before you provide personal or confidential information.
Please not the such website and its content have been construed in accordance with local laws and regulations, which may differ from the ones applicable to neuraxpharm.com/uk.
Please make sure to review the Privacy Policy and Legal Terms of any website located in a different geography before you provide personal or confidential information.
Please not the such website and its content have been construed in accordance with local laws and regulations, which may differ from the ones applicable to neuraxpharm.com/uk.
Please make sure to review the Privacy Policy and Legal Terms of any website located in a different geography before you provide personal or confidential information.
Please not the such website and its content have been construed in accordance with local laws and regulations, which may differ from the ones applicable to neuraxpharm.com/uk.
Please make sure to review the Privacy Policy and Legal Terms of any website located in a different geography before you provide personal or confidential information.
Please not the such website and its content have been construed in accordance with local laws and regulations, which may differ from the ones applicable to neuraxpharm.com/uk.
Please make sure to review the Privacy Policy and Legal Terms of any website located in a different geography before you provide personal or confidential information.
Please not the such website and its content have been construed in accordance with local laws and regulations, which may differ from the ones applicable to neuraxpharm.com/uk.
Please make sure to review the Privacy Policy and Legal Terms of any website located in a different geography before you provide personal or confidential information.
Please not the such website and its content have been construed in accordance with local laws and regulations, which may differ from the ones applicable to neuraxpharm.com/uk.
Please make sure to review the Privacy Policy and Legal Terms of any website located in a different geography before you provide personal or confidential information.
Please not the such website and its content have been construed in accordance with local laws and regulations, which may differ from the ones applicable to neuraxpharm.com/uk.
Please make sure to review the Privacy Policy and Legal Terms of any website located in a different geography before you provide personal or confidential information.
Please not the such website and its content have been construed in accordance with local laws and regulations, which may differ from the ones applicable to neuraxpharm.com/uk.
Please make sure to review the Privacy Policy and Legal Terms of any website located in a different geography before you provide personal or confidential information.
Please not the such website and its content have been construed in accordance with local laws and regulations, which may differ from the ones applicable to neuraxpharm.com/uk.
Please make sure to review the Privacy Policy and Legal Terms of any website located in a different geography before you provide personal or confidential information.
Please not the such website and its content have been construed in accordance with local laws and regulations, which may differ from the ones applicable to neuraxpharm.com/uk.
Please make sure to review the Privacy Policy and Legal Terms of any website located in a different geography before you provide personal or confidential information.
Please not the such website and its content have been construed in accordance with local laws and regulations, which may differ from the ones applicable to neuraxpharm.com/uk.
Please make sure to review the Privacy Policy and Legal Terms of any website located in a different geography before you provide personal or confidential information.
Please not the such website and its content have been construed in accordance with local laws and regulations, which may differ from the ones applicable to neuraxpharm.com/uk.
Please make sure to review the Privacy Policy and Legal Terms of any website located in a different geography before you provide personal or confidential information.
Please not the such website and its content have been construed in accordance with local laws and regulations, which may differ from the ones applicable to neuraxpharm.com/uk.
Please make sure to review the Privacy Policy and Legal Terms of any website located in a different geography before you provide personal or confidential information.
Please not the such website and its content have been construed in accordance with local laws and regulations, which may differ from the ones applicable to neuraxpharm.com/uk.
Please make sure to review the Privacy Policy and Legal Terms of any website located in a different geography before you provide personal or confidential information.